logo
logo
Sign in

The China Continuous Glucose Monitoring Devices Market Growth Accelerated by Rising Prevalence of Diabetes

avatar
Niranjan Mardakar
The China Continuous Glucose Monitoring Devices Market Growth Accelerated by Rising Prevalence of Diabetes

Continuous glucose monitoring devices are able to monitor blood glucose levels in real time, providing key advantages over traditional self-monitoring of blood glucose testing methods. These devices offer convenience to users and help improve glycemic control for those living with diabetes. The growing prevalence of diabetes has led to a higher demand for continuous glucose monitoring in China.

The China Continuous Glucose Monitoring Devices Market is estimated to be valued at US$ 176.4 Mn in 2023 and is expected to exhibit a CAGR of 22% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The growing prevalence of diabetes has been a key driver accelerating growth in the China continuous glucose monitoring devices market. An estimated 141 million adults in China currently have diabetes and prediabetes levels are highly prevalent as well, with changing diets and increasingly sedentary lifestyles contributing to climbing rates of the condition. Continuous glucose monitoring devices offer improved management of blood glucose for diabetes patients, helping them avoid dangerous hypo- and hyperglycemic events. The ability of these devices to alert users in real-time to changing glucose levels has made them increasingly popular for diabetes management in China. Rising awareness of the benefits of continuous monitoring over finger prick methods is further expected to support strong market growth over the forecast period.

Segment Analysis

The Global China Continuous Glucose Monitoring Devices Market Size is segmented into professional CGM systems and personal CGM systems. The personal CGM systems segment dominated the market in 2023 and is expected to continue its dominance over the forecast period. This is because personal CGM systems are affordable, easy-to-use, and non-invasive options that provide patients flexibility, especially for those with type 2 diabetes.

Key Takeaways

The global China continuous glucose monitoring devices market is expected to witness high growth over the 2023-2030 period. The China Continuous Glucose Monitoring Devices Market is estimated to be valued at US$ 176.4 Mn in 2023 and is expected to exhibit a CAGR of 22% over the forecast period 2023 to 2030.

The southern region of China accounted for the largest market share in 2023 and is projected to experience the fastest growth during the forecast period. This is due to the increasing prevalence of diabetes and rising disposable income in provinces such as Guangdong and Fujian that allow more patients to opt for CGM devices.

Key players

Key players operating in the China continuous glucose monitoring devices market are Medtronic PLC, Abbott Laboratories, Senseonics, STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc., Micron Technology Inc., Renesas Electronics Corporation, and Toshiba Corporation. Medtronic and Abbott collectively accounted for over 50% market share in 2023 owing to their diverse product portfolios and strong distribution networks across China.

Get More Insights On This Topic: https://www.newsstatix.com/china-continuous-glucose-monitoring-devices-market-size-share-analysis-2023-2030/

collect
0
avatar
Niranjan Mardakar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more